Mexico boosts cardiology services
This article was originally published in Clinica
Mexico city's general hospital has opened its new echocardiography and electrophysiology units, following the completion of the first phase of its cardiology services refurbishment programme. Phase two of the Peso 80 million ($8m) programme will comprise three new operating theatres and blood service units, with a capacity of around 300 patients a day. The programme is due to be completed in 2004.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.